Ubs Asset Management Americas Inc Dexcom Inc Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Dexcom Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 6,276,504 shares of DXCM stock, worth $422 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

6,276,504

Previous 4,349,060 44.32%

Holding current value

$422 Million

Previous $603 Million 17.97%

% of portfolio

0.21%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $213 Million - $271 Million	1,927,444 Added 44.32%	6,276,504 $712 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $3.75 Million - $4.59 Million	-32,788 Reduced 0.75%	4,349,060 $603 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $21.9 Million - $36 Million	290,155 Added 7.09%	4,381,848 $544 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $954,061 - $1.53 Million	-11,086 Reduced 0.27%	4,091,693 $382 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $25.4 Million - $30 Million	243,909 Added 6.32%	4,102,779 $477 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $27.9 Million - $40.2 Million	-327,741 Reduced 7.83%	3,858,870 $437 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $8.54 Million - $10.5 Million	111,825 Added 2.74%	4,186,611 $337 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $207 Million - $405 Million	3,044,735 Added 295.59%	4,074,786 $304 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $2.86 Million - $3.95 Million	30,352 Added 3.04%	1,030,051 $132 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $14.3 Million - $18 Million	-110,486 Reduced 9.95%	999,699 $134 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $4.29 Million - $5.75 Million	-40,183 Reduced 3.49%	1,110,185 $152 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $19.9 Million - $26.6 Million	246,065 Added 27.21%	1,150,368 $123 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $41 Million - $50.6 Million	483,505 Added 114.9%	904,303 $81.3 Million
Q4 2020 Mar 01, 2021	BUY	$78.0 - $104.5 $9.25 Million - $12.4 Million	118,554 Added 39.22%	420,798 $38.9 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $812,599 - $960,978	8,508 Added 2.9%	302,244 $31.1 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $1.22 Million - $2.05 Million	-19,495 Reduced 6.22%	293,736 $29.8 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.26 Million - $1.99 Million	26,317 Added 9.17%	313,231 $21.1 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $585,810 - $916,468	15,997 Added 5.9%	286,914 $15.7 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $150,576 - $185,624	4,238 Added 1.59%	270,917 $10.1 Million
Q2 2019 Aug 15, 2019	SELL	$27.84 - $38.92 $529,433 - $740,141	-19,017 Reduced 6.66%	266,679 $0
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $1.1 Million - $1.5 Million	39,351 Added 15.97%	285,696 $0
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $4.57 Million - $6.33 Million	169,265 Added 219.6%	246,345 $7.38 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $43,968 - $69,143	1,883 Added 2.5%	77,080 $0
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $98,943 - $142,266	-5,641 Reduced 6.98%	75,197 $0
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $108,620 - $154,197	8,317 Added 11.47%	80,838 $0
Q4 2017 Feb 09, 2018	SELL	$11.12 - $15.38 $2.16 Million - $2.99 Million	-194,226 Reduced 72.81%	72,521 $0
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $3.03 Million - $5.06 Million	266,747	266,747 $0

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Dexcom Inc Transaction History